EAM

Exome Asset Management Portfolio holdings

AUM $170M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+208.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
-$32.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$4.1M
2
+$3.95M
3
+$3.91M
4
BSX icon
Boston Scientific
BSX
+$3.87M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.57M

Top Sells

1
+$5.49M
2
+$5.26M
3
+$4.5M
4
IMVT icon
Immunovant
IMVT
+$4.03M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$3.91M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADAG
26
Adagene
ADAG
$219M
$2.89M 1.7%
736,845
-323,376
ARWR icon
27
Arrowhead Research
ARWR
$10.3B
$2.87M 1.69%
45,721
-4,037
CBIO
28
Crescent Biopharma
CBIO
$496M
$2.81M 1.66%
+153,191
RLAY icon
29
Relay Therapeutics
RLAY
$2.95B
$2.77M 1.63%
+278,302
MAZE
30
Maze Therapeutics
MAZE
$1.34B
$2.64M 1.55%
+88,510
CTMX icon
31
CytomX Therapeutics
CTMX
$653M
$2.45M 1.44%
521,468
-223,837
AVTX icon
32
Avalo Therapeutics
AVTX
$689M
$2.38M 1.4%
+159,341
GKOS icon
33
Glaukos
GKOS
$7.34B
$2.25M 1.32%
20,874
-10,597
CRBP icon
34
Corbus Pharmaceuticals
CRBP
$140M
$2.2M 1.29%
234,136
+94,593
PEN icon
35
Penumbra
PEN
$12.6B
$2.07M 1.22%
6,300
-2,700
SLNO
36
DELISTED
Soleno Therapeutics
SLNO
$2.06M 1.22%
+61,673
LQDA icon
37
Liquidia Corp
LQDA
$5.5B
$1.73M 1.02%
45,796
-45,352
ZBIO
38
Zenas BioPharma
ZBIO
$1.1B
$1.58M 0.93%
+80,730
NBP
39
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$1.42M 0.84%
576,960
+77,373
FDMT icon
40
4D Molecular Therapeutics
FDMT
$452M
$1.22M 0.72%
+130,564
NXTC icon
41
NextCure
NXTC
$10.7M
$1.22M 0.72%
115,500
-49,500
PALI icon
42
Palisade Bio
PALI
$302M
$1.05M 0.62%
600,000
-158,203
ESTA icon
43
Establishment Labs
ESTA
$2.19B
$744K 0.44%
13,100
LPCN icon
44
Lipocine
LPCN
$16.9M
$486K 0.29%
+60,861
ABUS icon
45
Arbutus Biopharma
ABUS
$840M
$340K 0.2%
75,484
ALDX icon
46
Aldeyra Therapeutics
ALDX
$98.3M
– –
0
AZN icon
47
AstraZeneca
AZN
$288B
– –
-28,362
BLTE
48
Belite Bio
BLTE
$5.75B
– –
-14,328
CELC icon
49
Celcuity
CELC
$4.31B
– –
-34,289
CMPX icon
50
Compass Therapeutics
CMPX
$367M
– –
0
1
2
3